Evolent Health (EVH) ROE US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | -5.42% | -2.23% | -10.6% | -6.15% | -128.7% | -125.3% | ||
| Changes by years, y/y, % | +49pp | +3pp | -8pp | +4pp | -123pp | +19.0% | |||
Evolent Health. ROE, %
Evolent Health. ROE, changes, pp
Evolent Health (EVH) ROE US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| ROE, % | ? | -11.6% | -14.6% | -15.2% | -128.7% | -125.3% | -125.3% | |
| Changes by years, y/y, % | -1pp | -7pp | -8pp | -123pp | -114pp | |||
| Changes by quarters, q/q, % | -5pp | -3pp | -1pp | -114pp | +3pp | |||